低剂量伊米基莫德通过ROS介导的途径诱导黑色素瘤细胞中的黑色素生
Zheng-Yi Li1, Shu-Hao Chang1, Kuang-Ting Liu2
1Institute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Journal of dermatological science
|January 7, 2024
概括
低剂量伊米基莫德 (IMQ) 通过通过ROS生产抑制酸化酶4B (PDE4B) 来激活黑色素瘤细胞中的黑色素生,从而导致黑色素的增加. 这一发现为黑色素瘤治疗提供了新的治疗途径.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 免疫学 免疫学 免疫学
背景情况:
- 黑色素生成对于皮肤紫外线保护和黑色素瘤抗原性至关重要.
- 伊米基莫德 (IMQ) 是一种托尔类受体7 (TLR7) 激动剂,具有抗病毒和抗癌性质.
研究的目的:
- 为了研究IMQ在诱导黑色素瘤细胞内的黑色素生成的潜力.
主要方法:
- 使用了黑色素瘤细胞系 (B16F10,MNT-1,C32,A375) 和黑色素细胞 (Melan-A).
- 评估了黑色素水平,与黑色素发生相关的蛋白质表达,细胞内循环AMP和化酶4B (PDE4B) 活性.
- 采用了包括免疫阻塞和cAMP Glo测试在内的技术.
主要成果:
- 低剂量IMQ触发了B16F10细胞中的黑色素生成,增加了色素.
- IMQ上调了与微相关的转录因子 (MITF) 和铁酶 (TYR) 活性.
- 黑色素发生与IMQ介导的PDE4B抑制,过度的cAMP积累和ROS产生有关.
结论:
- 低剂量IMQ通过ROS/PDE4B/PKA通路激活黑色素瘤细胞中的黑色素生.
- 这种机制涉及ROS诱导的PDE4B抑制,导致cAMP增加和随后的黑色素生成.
更多相关视频
06:09Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
8.8K
10:05Stimulation of Stem Cell Niches and Tissue Regeneration in Mouse Skin by Switchable Protoporphyrin IX-Dependent Photogeneration of Reactive Oxygen Species In Situ
Published on: May 8, 2020
2.0K
相关概念视频
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
